Pharmacological Analysis Demonstrates Dramatic Alteration of D<sub>1</sub>Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia
Amandine Berthet(Institut des Maladies Neurodégénératives), Bertrand Bloch(Université de Bordeaux), Erwan Bézard(Centre National de la Recherche Scientifique), Martine Cador(Victor (Japan)), Holger Stark(Heinrich Heine University Düsseldorf), Évelyne Doudnikoff(Victor (Japan)), Grégory Porras(Victor (Japan))
Cited by 135
Related Papers
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472